Inactive Instrument

News SPINEWAY Swiss Exchange

Equities

End-of-day quote Swiss Exchange Other stock markets
- ^EUR	-

04-17	Spineway: punished despite a solid first quarter	CF
04-16	Spineway SA Announces Revenue Results for the First Quarter of 2024	CI

SMISS Asia Pacific 2024 Congress and training program	06-26	AQ
Actions to strengthen presence in North Africa : Congress & Surgeons trainings	06-18	AQ
Partnership of Spineway with the SFCR for June 24 congress	06-10	AQ
Partnership with Key Opinion Leaders and successful trainings	05-30	AQ
Spineway: punished despite a solid first quarter	04-17	CF
Growth of 28% of 2024 first quarter revenue	04-16	AQ
Spineway SA Announces Revenue Results for the First Quarter of 2024	04-16	CI
2023 Shareholders General Meeting	03-26	AQ
Reverse stock split	02-29	AQ
Preparatory documents for the General Meeting as of of March 25, 2024	02-19	AQ
SPINEWAY : 2023 annual results	02-07	AQ
Spineway SA Reports Earnings Results for the Full Year Ended December 31, 2023	02-07	CI
Spineway: strong sales growth in 2023	01-26	CF
Increase of 2023 revenue at €10.5 million	01-25	AQ
Shares reverse split	01-05	AQ
SPINEWAY : International rollout of the VEOS implant range - First implants in Spain - New approvals in Colombia and Indonesia	11-24	AQ
Extraordinary General Meeting's minute	11-13	AQ
Spineway Names Deputy CEO	11-08	MT
Deputy Chief Executive Officer's appointment	11-07	AQ
Spineway Sa Announces the Appointment of Sandrine Carle as Deputy Chief Executive Officer	11-07	CI

No results for this search